Development of in-vitro models to investigate the intestinal lymphatic uptake of drugs

We aim to improve drug delivery by addressing a lack of accurate models predicting how drugs reach the body’s lymphatic system. Our innovative in-vitro models focus on understanding how drugs travel through the intestinal lymphatics. Using chylomicrons, lipid-based vesicles, our models simulate the journey of drugs from the intestines to the bloodstream. This success of this project promises valuable insights for drug development and regulatory assessments, ultimately improving treatments. The partner organization will gain valuable insights and the latest academic knowledge through our collaboration and this newfound knowledge can boost their ability to develop better products and might even speed up the process of getting approval for their products.

Faculty Supervisor:

Neal Davies

Student:

Partner:

RS Therapeutics Inc.

Discipline:

Life Sciences

Sector:

Manufacturing

University:

University of Alberta

Program: